$50M
Qualified
maximum offering price, as qualified
—
Reported Sold
no 1-K or 1-Z states a sold amount
3
Filings
across 1 offering
Equity Classes
| Type | Class | Outstanding |
|---|---|---|
| common | Common Stock | 50,308,155 |
Offerings
| File Number | Filings | First Filed | Last Filed | Qualified | Price/Security | Securities Offered | Outstanding | Aggregate Offering | Issuer Portion | Selling Holders | Prior 12mo Qualified | Concurrent Offering |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 024-11896 | 2 | 2022-05-27 | 2022-07-29 | 2022-08-03 | $5.80 | 8,620,689 | 50,308,155 | $50M | $42.4M | $7.6M | $0 | $0 |
The statements and reported figures behind Kurve Therapeutics, Inc.
Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.
- Every caption as the filer wrote it, across every annual report — not just the latest 1-K
- Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
- A sparkline on each annual-statement line, so the shape is visible before the figures
- A revenue series dated to the filings that reported it
- A filing history that says what each document contributed, not only that it exists
- Follow it, and see it change on your watchlist
Part of the Alts plan — $40/mo at launch pricing ($100 list)
External link: SEC Filings